Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Business
  • Tech
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Business

ReAlta Life Sciences Appoints Lewis T. Williams, M.D., Ph.D. as Chairman

  • The Pharma Data
  • November 22, 2024

ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on rebalancing the inflammatory response to treat rare and acute inflammatory diseases, has announced the appointment of…

Read MoreReAlta Life Sciences Appoints Lewis T. Williams, M.D., Ph.D. as Chairman
  • Press Releases

Altasciences Partners with Metsera for Early-Stage Obesity Clinical Trials

  • The Pharma Data
  • November 22, 2024

Altasciences is pleased to have supported Metsera, Inc., a clinical-stage biopharmaceutical company focused on advancing next-generation treatments for obesity and metabolic diseases, in its nonclinical and early-stage clinical trials. This…

Read MoreAltasciences Partners with Metsera for Early-Stage Obesity Clinical Trials
  • News

NorthStar and Cellectar Partner on Actinium-225 Supply Agreement

  • The Pharma Data
  • November 22, 2024

NorthStar Medical Radioisotopes, LLC, a leader in radiopharmaceutical innovation, has entered into a strategic Master Supply Agreement with Cellectar Biosciences, Inc. (NASDAQ: CLRB). Under the agreement, Cellectar will integrate NorthStar’s…

Read MoreNorthStar and Cellectar Partner on Actinium-225 Supply Agreement
  • Research

Institut Curie Adopts Ibex Medical Analytics AI Tools to Advance Cancer Diagnostics

  • The Pharma Data
  • November 22, 2024

Ibex Medical Analytics (Ibex), a leader in AI-powered cancer diagnostics, has announced the integration of its advanced AI solutions into routine clinical practice at Institut Curie, one of the world’s…

Read MoreInstitut Curie Adopts Ibex Medical Analytics AI Tools to Advance Cancer Diagnostics
  • News

Trinity Life Sciences Advocates Transformative Approach to Evaluating Field Medical Affairs Impact

  • The Pharma Data
  • November 22, 2024

Trinity Life Sciences, a leader in strategy, insights, and analytics for the life sciences industry, has introduced a groundbreaking approach to evaluating the impact of Field Medical Affairs in its…

Read MoreTrinity Life Sciences Advocates Transformative Approach to Evaluating Field Medical Affairs Impact
  • Business

Omeros Corporation Shares Update on BLA Resubmission Progress

  • The Pharma Data
  • November 22, 2024

Omeros Corporation (Nasdaq: OMER) has shared an update on its ongoing efforts to resubmit the biologics license application (BLA) for narsoplimab, its first-in-class antibody targeting MASP-2, a key enzyme in…

Read MoreOmeros Corporation Shares Update on BLA Resubmission Progress
  • Business

Pfizer Appoints New Chief Scientific Officer and President of R&D

  • The Pharma Data
  • November 21, 2024

Pfizer Inc. (NYSE: PFE) has announced the appointment of Chris Boshoff, M.D., PhD, as its new Chief Scientific Officer and President of Research & Development, effective January 1, 2025. Dr.…

Read MorePfizer Appoints New Chief Scientific Officer and President of R&D
  • News

EU Approves Pfizer’s HYMPAVZI™ for Severe Hemophilia A/B in Adults and Adolescents

  • The Pharma Data
  • November 21, 2024

Pfizer Inc. (NYSE: PFE) has received marketing authorization from the European Commission (EC) for HYMPAVZI™ (marstacimab) for the routine prevention of bleeding episodes in patients aged 12 years and older,…

Read MoreEU Approves Pfizer’s HYMPAVZI™ for Severe Hemophilia A/B in Adults and Adolescents
  • Press Releases

Tasfygo® Tablets 35mg Launched in Japan for FGFR2-Positive Biliary Tract Cancer

  • The Pharma Data
  • November 21, 2024

Eisai Co., Ltd. has announced the launch of TASFYGO® Tablets 35mg (generic name: tasurgratinib succinate) in Japan for the treatment of patients with unresectable biliary tract cancer harboring FGFR2 gene…

Read MoreTasfygo® Tablets 35mg Launched in Japan for FGFR2-Positive Biliary Tract Cancer
  • Business

Bio-Techne Signs Distribution Agreement with Leader Life Sciences

  • The Pharma Data
  • November 21, 2024

Bio-Techne Corporation (NASDAQ: TECH), a leading global provider of innovative tools and bioactive reagents for research and clinical diagnostics, has announced a strategic partnership with Leader Life Sciences. Under this…

Read MoreBio-Techne Signs Distribution Agreement with Leader Life Sciences
  • Press Releases

Improving Access to Pediatric Medicines on World Children’s Day

  • The Pharma Data
  • November 21, 2024

On World Children’s Day, the Global Accelerator for Paediatric Formulations Network (GAP-f) highlighted the urgent need for better access to essential medicines for children, particularly in low-resource settings. Despite their…

Read MoreImproving Access to Pediatric Medicines on World Children’s Day
  • News

Local Climate Action, Global Health Benefits

  • The Pharma Data
  • November 21, 2024

On Wednesday, November 20, the UN Climate Conference (COP29) in Baku, Azerbaijan, spotlighted urbanization and transportation as critical areas for climate action. The day emphasized the pivotal role of cities…

Read MoreLocal Climate Action, Global Health Benefits
PrevNext
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • HistoSonics Secures New Financing Round Backed by Yosemite and Other Strategic Investors
  • Arrowhead Wins EU Approval for REDEMPLO in Familial Chylomicronemia Syndrome
  • Trace Neuroscience Launches Global Clinical Program for ALS Therapy TRCN-1023
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.